Caricamento...
Designer receptor technology for the treatment of epilepsy
Epilepsy remains refractory to medical treatment in ~30% of patients despite decades of new drug development. Neurosurgery to remove or disconnect the seizure focus is often curative but frequently contraindicated by risks of irreversible impairment to brain function. Novel therapies are therefore r...
Salvato in:
| Pubblicato in: | EBioMedicine |
|---|---|
| Autori principali: | , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Elsevier
2019
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6558262/ https://ncbi.nlm.nih.gov/pubmed/31078519 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ebiom.2019.04.059 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|